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ABSTRACT
A possible mechanism of pathogenicity of Bacteroides fragilis was
determined while studying the interaction of rabbit peritoneal polymorphonuclear neutrophils (PMN neutrophils) with Bacteroides products
(outer membrane and culture supernatant
and

~·

of~·

fragilis VPI 9032, VPI 2553

vulgatus VPI 4245; culture supernatant of B. thetaiotaomicron

VPI 5482; and LPS

of~·

fragilis VPI 9032) .

Neutrophils were elicited by

injection of glycogen into the peritoneal cavity of rabbits and harvested
four to seven hours later.
When rabbit peritoneal neutrophils were exposed to Bacteroides
products, the neutrophils released N-acetyl- S-glucosaminidase, a
lysosomal enzyme.

Bacteroides products also induced directional locomo-

tion (chemotaxis) of rabbit PMN neutrophils in Boyden chambers.

The

chemotactic response of rabbit neutrophils was dependent on the dosage
of Bacteroides stimulant.
The enzyme release response was greatly enhanced when Bacteroides
products were pre-incubated at 37°c for 30 minutes with equal volumes of
fresh guinea pig complement.

However, when Bacteroides outer membrane or

sterile culture supernatants were pre-incubated with fresh guinea pig
complement, PMN neutrophil chemotaxis was retarded.
Lactate dehydrogenase (a cytoplasmic marker) was not released upon
exposure of rabbit PMN neutrophils to Bacteroides products.

This

indicated that the response to Bacteroides products reflect an active
extracellular secretion of PMN neutrophil lysosomal contents rather than
iii

a non-specific discharge of enzymes as a result of cell (PMN neutrophil)
death.
These findings suggest an altered inflammatory response of neutrophils during the interaction of Bacteroides with the host defense
mechanism.

iv

DEDICATION
To my family

v

ACKNOWLEDGMENTS
I would like to express my appreciation to Dr. Jay Sperry for his
criticisms and advice, for which I am grateful, and most of all for
his encouragement when my authorship seemed to be faltering.
I owe much to Dr. Donald L. Kruetzer of the University of Connec-

ticut Health Center, Farmington, Connecticut, who supplied some reagents
and chemotaxis chambers used in this study; his practical assistance was
indespensable.
I also would like to thank members of my thesis committee, Dr. David

Laux and Dr. Kerwin Hyland for their assistance.
Finally I acknowledge with deep appreciation the loving support and
understanding of my wife, Ms. Jacque 1 , and daughter, Olcf Tokumbo who
made writing this manuscript at home possible.

vi

TABLE OF CONTENTS
Page
Abstract .......................................................

iii

Acknowledgments

vi

List of Figures ........................................... . ....

viii

List of Tables ··:··············································

ix

Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1

Literature Review . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4

Materi a 1 and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

22

Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

33

Discussion

49

Appendices

57

Literature Cited ...............................................

60

vii

LIST OF FIGURES
FIGURE
1

PAGE

Dose response of rabbit PMN neutrophils to Bacteroides
fragilis (VPI 5383) outer membrane .......................... 36

2

Locomotion of rabbit PMN neutrophils in established
gradients of Bacteroides vulgatus VPI 4245 outer membrane ... 38

viii

LIST OF TABLES
PAGE

TABLE
1

Chemotactic response of rabbit PMN neutrophils to
the defined medium of Varel and Bryant .................... 37

2

Rabbit PMN neutrophils response to Bacteroides
fragilis cellular components or products in the
presence and absence of guinea pig complement ............. 39

3

Rabbit PMN neutrophils chemotactic response to
C5 fragment in the presence and absence of
Bacteroides fragilis VPI 4383 cellular components
or products ............................................... 40

4

N-acetyl- B-glucosaminidase activity released from
cytochalasin B-treated rabbit PMN neutrophils in
response to cellular components or products of
Bacteroi des. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

5

N-acetyl- B-glucosaminidase activity released from
cytochalasin B-treated rabbit PMN neutrophils in
response to Bacteroides cellular products or
components pre-incubated at 37°c with guinea pig
complement for 30 minutes ................. . ............... 42

ix

INTRODUCTION
In recent years increasing emphasis has been placed on the role of
obligately anaerobic microorganisms as the etiological agents of many
human diseases.

Bacteroides is the most common anaerobic organism

isolated from bacteremia, intra-abdominal infections, and female genital
tract infections (29, 39-44, 53, 62, 63, 71).

Bacteroides fragilis

attracts the most concern among the anaerobic non-sporing gram negative
bacteria because it has been the most frequent clinical isolate (39-44,
71).

Bacteroides fragilis constitutes 60% of the strains of Bacteroides

isolated from blood cultures, lung abscesses, soft tissues, infections
of the intestinal and urogenital tracts (29, 71).

Although~·

vulgatus

and B. thetaiotaomicron are the most frequent fecal isolates and outnumber~·

fragilis in the large intestine of man (41);

the predominant in intra-abdominal sepsis (29, 44, 62).
unique because of its resistance to the

~·

fragilis is
~·

fragilis is

S- lactam antibiotics (e.g.

penicillin and cephalosporin) (44, 53).
Common predisposing factors for Q_. fragilis infections are trauma
(including surgery, perforating injuries, deliveries and abortions),
vascular defects of the mucosal surfaces, systemic conditions such as
diabetes melitus, leukemia, alcoholism, malignancy and immunosuppressive
therapy which alter resistance to microbial invasion.

Earlier views

that anaerobes were present in infectious processes as microbial
commensals with no role in the septic processes have been disproved by
many studies (29, 39-44, 71).
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Despite increased awareness of the importance of Bacteroides in
infectious processes, relatively little information is available regarding specific humoral and cellular host defense mechanisms against these
gram negative non-sporing anaerobic microorganisms (10, 63) or the
mechanism responsible for their pathogenicity (29, 61, 71).
However, some studies have been done on the interactions between
Bacteroides fragilis lipopolysaccharide and PMN neutrophils during
inflammation (77, 78).

An inflammatory response results from any injury

to the tissue (e.g. following a mechanical injury or establishment and
multiplication of microorganisms).

The inflammatory response is a major

mechanism used by the mammaliam immune system to destroy potentially
toxic materials (59).

Generally, inflammatory infiltrates are predomin-

antly PMN neutrophils (30).

The accumulation of PMN neutrophils is of

major importance to the host, since these neutrophils are intimately
involved in the host defense against microbial invasion and in certain
inflammatory disease states the neutrophils appear to be responsible
for a large degree of the host-tissue destruction (as in acute necrotizing
gingivitis) (73, 76, 79, 80, 89).
The importance of complement in generating neutrophil chemotactic
activity in serum reacted with immune complexes (antigen-antibody complexes) was first demonstrated by Boyden in 1962 (14).

More recently,

Ward and others (85, 87, 90), have shown that serum complement is
involved in opsonization, phagocytosis, vascular changes of acute
inflammation and in amplifying the accumulation of phagocytes (neutrophils)
at sites of chronic inflammation.
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Phagocytosis and intracellular killing of microorganisms is a primary
protective function of PMN neutrophils (10, 12, 14, 73).

Bacteria produce

soluble, diffusable materials (factors) detectable by PMN neutrophils some
distance away (81).

The PMN neutrophils unidirectionally migrate in the

chemical gradient toward the source of the attractant.

Polymorphonuclear

neutrophils contain a wide variety of hydrolytic enzymes and substances
which are directly responsible for the killing and digestion of bacteria
and other engulfed particles (2, 4, 49, 50).
Once at the inflammatory site, neutrophils also may release enzymes
that intensify the influx of additional neutrophils as well as modulate
the influx of mononuclear cells (89).

The early local accumulation of

these neutrophils at the sites of microbial invasion should aid in the
rapid destruction of microorganisms and in healing of wounds.

On the

other hand, factors that delay or inhibit this early PMN neutrophil
accumulation such as neutropenia, endotoxin (73), adrenalin administration or anti-inflammatory drugs, would allow for proliferation and
probable dissemination of microorganisms in the host.
The objective of this research was to investigate a potential mechanism of pathogenicity of Bacteroides fragilis by correlating in vitro
chemotaxis of, and enzyme release by PMN neutrophils in response to
Bacteroides fragilis, with i!!_ vivo virulence.
Bacteroides products

The interactions of

~terile culture filtrates (bacterial factors), outer

membrane, and lipopolysaccharideLJ with PMN neutrophils which constitute
the first line of the defense mechanism were determined and evidence
was provided to support the hypothesis concerning the nature of the
initial host response following contamination with B. fragilis.
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LITERATURE REVIEW
Polymorphonuclear (PMN) neutrophil responses to serum complementderived chemotactic factors, synthetic peptides and bacterial chemotactic factors have been investigated for a number of years (32, 46, 70,
84); however, a clear relationship between these factors and PMN
neutrophils is yet to be defined.

The majority of this work has been

done with complement-derived chemotactic factors and synthetic peptides
and little is known about chemotactic factors produced by bacteria.
Infectious Microorganisms and Chemotaxis
Although many pyogenic bacteria produce factors chemotactic for
neutrophils, little or nothing has been done to purify or identify
these chemotactic factors.

Keller and Sorkin showed that culture fil-

trates of Staphylococcus aureus and Escherichia coli were chemotactic
for PMN neutrophils (46, 47}; but they did not purify or identify the
active components nor did they determine whether any difference existed
between these two preparations.

Ward, Lepow and Newman examined several

bacteria isolated from human infections (91).

They demonstrated that

sterile culture filtrates from i· aureus, 0(-hemolytic streptococci,
Streptococcus pneumoniae, f. coli, Pr oteus mirabilis, Proteus rettgeri
and Hafnia species contained substances chemotactic for PMN neutrophils.
Again these factors went essentially uncharacterized, except for a
chemotactic factor produced by i· pneumoniae.

The pneumococcal factor

was described as heat-stable and non-dialyzable (91).
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Besides producing factors chemotactic for neutrophils, bacteria
also produce inhibitors of chemotaxis.

s.

Bacterial toxins produced by

aureus and Clostridium perfringens inhibit neutrophil chemotaxis

(93, 96).

Weksler and Hill examined the effects of staphylococcal

mucopeptide on the acute inflammatory response by evaluating its effects
upon migration of PMN neutrophils (93).

They showed that mucopeptide

from a virulent strain of i· aureus, NCTC 9787, but not NCTC 7121 which
was less virulent, inhibited the migration of PMN neutrophils toward a
chemotactic stimulus in a Boyden Chamber (93).

Virulent strains not

only inhibit -in vitro chemotaxis, but also enhance in vivo
- mouse virulence in experimental infections. Hill previously demonstrated that
mucopeptide from a mouse-virulent strain of i· aureus inhibited early
edema and permitted lesion formation (93).
Anaerobic Gram Negative Bacterial Products
Kasper and Onderdonk have demonstrated that Bacteroides fragilis,
an anaerobic, non-motile, gram negative bacillus has a cell wall similar
to most gram negative bacteria (39-44, 62, 63).
complex

of~-

The outer membrane

fragilis contains a protein-lipid bi-layer with two poly-

saccharide components.

One of the polysaccharide components, the lipo-

polysaccharide (endotoxin) was immunochemically and biologically identical
to the lipopolysaccharide (LPS) extracted by the phenol-water technique
(38, 40).

The two polysaccharides were described as sharing hexose,

hexosamine and methyl-pentoses.
Hofstad and Kristoferson reported that LPS from~- fragilis NCTC
9343, extracted by hot water-phenol lacked 2-keto-3-deoxyoctonate (KOO)
and heptose, essential components of the inner core of most bacterial
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LPS (37).

The biologically active component of LPS is the KOO/lipid A

region and the serological specificity of the glycolipid of the LPS is
determined by the sugar residues attached to KOO (67).
The LPS of gram negative bacteria contributes to virulence by
inhibition of phagocytosis and by direct toxic effects (62).
the LPS

of~·

However,

fragilis differs from other gram negative bacteria, since

it basically lacks toxicity (39-44, 62).
Bacteroides LPS induces PMN neutrophil chemotaxis
vitro through the activation of complement (46, 77).

~vivo

and in

Sveen et al showed

that Bacteroides LPS was consistently less cytotaxigenic than the reference endotoxin (Salmonella LPS), Fusobacterium LPS and LPS from
Veillonella {77, 78).
Muschel suggested that the presence of a capsular polysaccharide
may be responsible for the resistance of the organism to the bactericidal
activity of the complement-antibody system (39).
by Kasper

et~ that~·

Subsequent observations

fragilis is encapsulated while other species of

Bacteroides are not, focused attention on the capsule
a major virulence factor (38, 39, 42).

of~·

fragilis as

Kasper, Onderdonk and others

demonstrated that the "capsular polysaccharide of B. fragilis was not an
absolute requirement for abscess formation" in their rat experimental
model even though "its presence correlated well with the percentage of
recipients of abscesses" (62).
The report of Lindberg

et~

differed from that of Kasper demon-

strating that only 77% of~· fragilis and that 17% of~· ovatus,
~·

distasonis, ~· vulgatus, ~· uniformis and~· thetaiotaomicron isolated

from clinical infections were encapsulated (53).

The fact that an
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antibody response to the capsular polysaccharide

of~·

fragilis has been

demonstrated (42) further supports the pathogenic potential of an encapsulated Bacteroides.

However, the outer membrane complex of Bacteroides

is probably the best candidate for studying the virulence of Bacteroides
{43) . The outer membrane contains the most important immunologic antigens, and because of its location, the outer membrane is most readily
accessible to the host defense mechanisms (43, 62).
Classes of Neutrophil Chemotactic Factors
Bacteria elaborate chemotactic factors in two ways:
(i)

they release small peptides of approximately 1,000
molecular weight or larger (85) during bacterial
replication (81, 85).

These substances which directly

stimulate directional migration of leukocytes are
thought to attach to a site on the responding cell
(46, 85, 96).
named
(ii)

11

These chemotactic factors have been

cytotaxins" by Keller and Sorkin (46).

they release enzymatic materials which cleave specific
components of serum complement (third or fifth complement components) into chemotactically active fragments
(C5fr and C3fr).

These substances which have been

named "cytotaxi gens" ( 46), 1ack the abi 1ity to directly
stimulate locomotion in responding cells.

Cytotaxigens

unmask the presence of chemotactic mediators in serum
resulting in the release of endogenous cytotaxins (12, 46).
Harris, using time-lapse photography, provided strong evidence that
bacteria elaborate factors chemotactic for neutrophils.

He reported
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that neutrophils in suspension moved about randomly; but, cells placed
in the presence of bacteria moved unidirectionally toward a bacterium
or its product(s) (91).
Endogenous Complement Chemotactic Factors
Complement is a series of nine proteins and is involved in several
enzyme cascades in plasma.

These cascades include, the coagulation

system, the kinin system and the properdin system (92).

During activa-

tion of complement and properdin, products are elaborated which:

mediate

changes in vascular permeability, attract PMN neutrophils and mononuclear
cells, influence the release of lysosomal enzymes, enhance phagocytosis
by promoting adherence of complement-coated complexes to formed elements
in the blood (immune adherence) and damage cell membranes to induce
osmotic lysis and cell death (2S, 8S, 92).
Snyderman et

~have

demonstrated that CSfr (CSa) is the major

chemotactically active complement fragment derived through cleavage of
complement by immune complexes (72, 73).

They have also reported that

interaction of endotoxin (LPS) with guinea pig complement (C') .1I!. vitro
generated a low molecular weight chemotactic factor derived from C'S
(72, 73).

Trypsin (73, 91), cobra venom factor (72, 92), virus infected

cells (2S, 9S), streptococcal protease (89), and gram negative bacterial
protease (2S, 60, 86) also have neutrophil cytotaxigenic activity.

Ward

and Hill identified the lysosomal protease isolated from rabbit neutroPhils and showed that this protease could cleave human C'S into chemotactic fragments of variable molecular weights (89).
Ward, Cochrane and Muller-Eberhard reported that CS67, a heatstable factor, was chemotactic for neutrophils (81, 88).
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C'3 fragment (C3a), a peptide, was also shown to be chemotactic
(84) and anaphylatoxic (96).

It is cleaved from C1 3 by the action of

plasmin (84, 91), trypsin (99), tissue protease (90) and gram negative
bacterial protease (84, 86, 96).
Other proteins and some polysaccharides, for example peptone
medium (46) and glycogen (9, 46, 73, 90) are cytotaxigenic; while products of cell damage and the supernatants from homogenized granulocytes
are neutrophil cytotaxins (12, 90).
Vasoactive substances such as bradykinin, kallidin, histamine and
serotonin give no significant neutrophil chemotactic response (88).
Role of Complement in Chemotaxis and Infections
The role of serum complement in immune lysis (57), inflammation
and in resistance to bacterial infections (5, 59) is well known.

The

complement system has been strongly implicated as the biologic mediator
of acute inflammation (33-36) which mobilizes immune effector cells to
an inflammatory lesion (73, 74, 90).

This biologic activity is said to

be mediated by activated complement components, C3a and C5a, which are
believed to amplify the cellular components of the inflammatory response
(30, 33, 73).
Complement depletion affects the pathology of necrotic skin lesions.
Easmon and Glynn induced skin lesions in animals with Staphylococcus
aureus and showed that the ultimate dimensions of the lesions were proportional to the number of PMN neutrophils in the early infiltrate (21).
Tissue enzymes, capable of activating the complement system, released
by neutrophils have been implicated in tissue destruction and associated
with the infectious lesions (49).
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Complement C5fr is not only chemotactic but, it can trigger
neutrophils to undergo a burst of oxidative metabolism (13, 51).

During

this oxidative burst, oxygen is taken up from the extracellular medium
and converted to superoxide anion (02) which leads to generation of
hydrogen peroxide which coupled with halides (iodide, chloride) may act
as substrate for the halogenation and destruction of bacteria by the
myeloperoxidase system (13, 51).

Formylated methionyl-tripeptides

(e.g. N-formyl-methionyl-leucyl-phenyalanine) induce similar oxidative
bursts in responding neutrophils.
The importance of complement is highlighted by the findings that
C'S-deficient mice showed deficient PMN neutrophil accumulation in
response to local endotoxin; furthermore, these animals were more susceptible to microbial invasion than their CS-normal counterparts (73, 90).
Although phagocytosis can proceed in the absence of complement
activation, complement receptors on PMN neutrophils are important for
clearance and phagocytosis of opsonized particles.

Lay~~

reported

complement factors (first 4 complement components) mediate binding of
antigen-antibody complexes to neutrophil membranes during phagocytosis
(48).

Immunoglobulin and components of the alternative complement pathway
participated in the opsonization of!!_. fragilis and!!_. thetaiotaomicron
by promoting phagocytosis and intracellular killing (10).

The Bjornsons

showed that human serum depleted of immunoglobulin, C'3, factor B or D
did not support human PMN neutrophil phagocytosis and intracellular killing
of!!_. fragilis and B. thetaiotaomicron (10).
Casciato

et~

reported that under aerobic conditions, clinical

isolates of B. fragilis and B. thetaiotaomicron were not susceptible
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to human serum bactericidal activity (10).
demonstrated that under anaerobic

The Bjornsons

conditions~-

fragilis

however,
and~·

thetaiotaomicron were phagocytosed and killed intracellularly by human
PMN neutrophils in the presence of normal serum but not by either

neutrophils or serum alone (10).
Peterson

et~

found that two major opsonic systems in serum were

required for normal phagocytosis for staphylococci.

One was a heat-

labile system dependent on C' and the other a heat-stable system mediated
by immunoglobulin (64).

Cellular Physiology of the Chemotactic Response
Relationships between Chemotaxis, Enzyme release and Phagocytosis.
Chemotaxis, phagocytosis and lysosomal enzyme release are all examples of movement.

In chemotaxis, there is movement of the whole cell

(7-9, 46); in phagocytosis, movement of the cell membrane and associated
structures; and in lysosomal enzyme release the granules move from the
interior of the cell to the plasma membrane (9, 92).

Similar recognition

mechanisms are thought to be responsible for both chemotaxis and phagocytosis (9, 96).

Chemotaxis, phagocytosis and enzyme release require

glycolysis for metabolic energy (8, 25, 96).
and Becker

et~

Studies by Kreutzer

et~

demonstrated requirements for magnesium and calcium

ions for optimal chemotaxis (8, 22, 70).
In the absence of phagocytosis, enzyme release can occur by a process
of "reverse endocytosis 11 (33, 34, 80) or exocytosis.

This was demonstrated

by experiments employing PMN neutrophils exposed to non-phagocytosable
stimuli such as:

large aggregates of dead or living plaque bacteria (80),

irrrnune complexes attached to solid surfaces, surfaces too large to be
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phagocytosed (33, 35), or sepharose beads coated with C'3b and immunoglobulin (80).

Electron microscooic studies revealed that exocytosis

was apparently similar to the process following phagocytosis during
which granular contents are discharged into the phagocytic vacuoles
(35, 85).

The only difference is that in exocytosis granules are dis-

charged directly to the outside of the cell, since the whole surface
could not be engulfed by the PMN neutrophil.
The respiratory burst and enhancement of hexose monophosphate
shunt observed during phagocytosis is observed in cells stimulated by
chemotactic factors (7, 35, 85, 95).

Ward and others showed that

interaction of neutrophils with chemotactic factors resulted in a
respiratory burst, activation of hexose monophosphate shunt and production of lactate (35, 85).

These results were interpreted to mean that

similar or parallel metabolic pathways are required for chemotaxis and
phagocytosis.

Becker et al demonstrated that the ability of a peptide

(C5a or low molecular weight peptide isolated from£. coli culture
filtrate) to induce PMN neutrophil migration correlated directly with
its ability to induce lysosomal enzyme release from cytochalasin
S-treated cells (70).
Ward and Becker reported that the same enzyme, esterase 1, is
activated both during chemotaxis and phagocytosis.

Furthermore, in the

absence of this enzyme, neither of these functions (chemotaxis and
phagocytosis) can take place (7, 87).

Bacterial factors, for unknown

reasons, appear to activate a smaller proportion of the proesterase 1
(inert form of esterase 1) of neutrophils than do complement derived
chemotactic factors (7).
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Ward and Becker found that after responding to a complement derived
chemotactic stimulus (e.g. C567, C5fr, C3fr), PMN neutrophils became
"deactivated 11 and were not able to respond chemotactically a second time,
either to the same stimulus or any other chemotactic stimulus including
bacterial factors (7, 86).

In contrast, they reported that response of

rabbit PMN neutrophils to bacterial factors or incubation of the PMN
neutrophils with the bacterial factors did not induce deactivation to
the bacterial factor nor to any of the complement derjved factors (7).
Keller and Sorkin showed that although the phagocytosing neutrophil becomes unresponsive, it releases factors which attract other cells to the
site of action (96).

Microfilaments and Microtubules in the Chemotactic Response.
The current hypothesis to explain the chemotactic response is that
the microtubule system provides the net vector (polarized pseudopod
formation) while the microfilament system, which requires local increases
in cytoplasmic membrane calcium, provides the mechanical work for the
motion of the neutrophil (26).
The exact role of microtubules is unclear; however, evidence points
to the view that they direct lysosomal granules toward stimulated external membrane with which they interact (92).
Microtubules may act as a cytoskeleton, maintaining the shape of the
cell and in so doing aid movement of some distant granules to the vacuoles
(92).

The microfilaments (actinomysinoid material), which are contractile

elements of the cell, are involved in secretion (92).

Microfilaments

also may move granules around in the cytoplasm and normally prevent access
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of granules to the cell membrane; but by contracting, they allow freer
access of granules to the cell membrane.
Cytochalasin B, a fungal metabolite, paralyzes the microfilament
system and reversibly inhibits the chemotactic migration of human and
rabbit PMN neutrophils (36, 96, 100, 101).

There is speculative evi-

dence that cytochalasin B, by disrupting microfilaments, allows greater
movement of granules within the cytoplasm and thus enhances exocytosis
of granules from PMN neutrophils (92).
One role of microtubules, another contractile system in PMN neutrophils, has been suggested by the findings that colchicine and vinblastin (drugs which cause disruption of microtubules in human and
rabbit neutrophils), inhibit neutrophil motility and lysosomal enzyme
release at similar dose level (25, 92, 96).

Therefore, it appears

that secretion of lysosomal enzymes and chemotaxis depend upon the
integrity of the cells' contractile elements

Chemotaxis and Inflammation - Role in Host Defense
Chemotaxis and Chemokinesis.
In leukocyte chemotaxis, cells move unidirectionally toward the
point of the highest concentration of the attractant, where they accumulate and movement against this gradient is inhibited.
"positive chemotaxis" (25, 46, 84, 96).

This is called

Leukocytes may also migrate

away from the source of a chemical gradient.

This repulsion is called

"negative chemotaxis" (96).
Chemokinesis (random walk) has been defined as "a reaction by
Which the speed or frequency of locomotion and/or the frequency and
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magnitude of turns of the cells is determined by the substances in the
environment" (25, 95).

Substances that only increase the rate of

locomotion without influencing directional migration of cells, may not
necessarily cause the cells to accumulate; because once the cells reach
the source of such substances there is no force to prevent them from
moving away (96).

Keller and Sorkin suggested that random motility and

chemotaxis involve different cellular processes (46).

They further in-

dicated that rabbit neutrophil chemotactic activity could be diminished
without affecting random motion.

Role of PMN Neutrophils in Host Defense
Neutrophils, the classical cells of the inflammatory response, are
considered part of the host's first line of defense (81).

The role of

PMN neutrophils in host defense reactions is related to their ability
to engulf and destroy a wide variety of microorganisms (2, 19).
Cohn and Hirsch reported the presence of destructive products in
PMN neutrophil lysosomes and that these products are released during
phagocytosis (19).

The initial bactericidal event which occurs in the

cytoplasm of the neutrophil may be mediated by a number of antimicrobial
agents

~.g. phagocytin (a lysosomal cationic protein), lysozyme (94),

and lactic acid present in the neutrophil in high concentrations and
with potent activitie~

(19, 49, 76).

In addition, neutrophils contain

a variety of hydrolytic enzymes which may play a synergistic role in
the digestion of engulfed particles; even though these enzymes are not
directly responsible for bacterial inactivation (19).
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Ronston suggested that the phagocytic N-acetyl- S-glucosaminidase,
a hydrolytic enzyme of rabbit and human neutrophil lysosomes, may act
synergistically with several intracellular enzymes to degrade Group A
streptococcal cell wall within the PMN neutrophil (3).
Electron microscopic studies by Taichman et

~indicated

that

degranulation and discharge of PMN neutrophil lysosomal enzymes were
associated with phagocytosis of gram negative and gram positive bacteria,
and with exocytosis of lysosomes from cells contacting large masses of
aggregated plaque bacteria (80).

Lysosomal Granules of Neutrophils.
Two major granule types have been reported for PMN neutrophils:
(i)

a peroxidase positive granule (called

11

azurophil 11 or

11

specific 11 or

primary granule)
(ii)

a peroxidase negative granule (called

secondary granule) (33, 36, 76, 94, 95, 99).
In rabbit neutrophils, the azurophilic granules contain acid hydrolases,
whereas the specific granules contain alkaline phosphatase, lysozyme
and lactoferin but are free of acid phosphatase (4, 33, 76).
Myeloperoxidase has been used as a marker for azurophilic lysosomal
granules and lysozyme is commonly used as a marker for specific granules
even though lysozyme is not solely restricted to the specific granules
(94).
Neutrophils, during chemotaxis or stimulated by either phagocytosis
or adherence to non-phagocytosable surfaces, release 8-glucuronidase,
8-galactosidase, acid phosphatase and myeloperoxidase (which are known
to reside mainly in the primary

11

lysosomal 11 or azurophilic granule) (33).
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The presence of N-acetyl- 8-glucosaminidase activity in mammalian
tissues has been reported by several investigators (3, 61, 65, 98) .
Ayoub and McCarthy demonstrated the occurence of N-acetyl- 8-glucosaminidase activity in mammalian neutrophils (3).

They showed that N-acetyl-

S-glucosaminidase from phagocytic cells differed greatly from that obtained from soil bacilli.

Sellinger, Hay and others studied the intra-

cellular distribution of N-acetyl- 8-glucosaminidase, an acid hydrolase,
in various tissues (3).

They showed this enzyme to be lysosome-asso-

ciated.

llTITiunologic Release from Polymorphonuclear Neutrophils.
Although several reports suggest that extracellular release of
granular enzymes is a useful function of the inflammatory cell defending
the body; it has also been suggested that in protecting the host from a
generalized infection, the neutrophil may cause tissue damage at the
site of phagocytosis (80, 81, 87).
In immune vasculitis, tissue injury results from the inflammatory
response itself rather than from the stimulus that evoked the response
(87, 99).

Neutrophils contain injurious constituents within their

granules (e.g. Lysozyme).

Neutrophil accumulation at the site of immune

complex deposition is also accompanied by the phagocytosis of the complexes (33, 35).

During this process, some of the neutrophil granular

contents may escape to the outside of the cell and cause tissue damage.
Henson demonstrated that during exocytosis, granules are extruded directly
to the outside environment of the cell (35) .
such cases.

Tissue damage occurs in

Some examples of this are acute necrotizing, ulcerative
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gingivitis and juvenile periodontal infections, where evidence showing
that while phagocytosing large aggregates of plaque bacteria (by
exocytosis), PMN neutrophils cause tissue destruction (18, 32, 80, 81).
The release of bactericidal and bacteriostatic agents from neutrophils affects not only neutralization and killing of microorganisms,
but also amplifies and localizes the inflammatory response (27, 99).
Goetz and Austen have described a "neutrophil-immobilizing factor"
released from PMN neutrophils following exposure to bacterial endotoxin
(27).

This immobilizing factor inhibited the response of human neutro-

phils to diverse chemotactic stimuli without affecting cell viability.

Drugs Which Affect Chemotaxis
Henson and others have reported that cytochalasin B prevents
phagocytic uptake of particles by
microfilaments (35, 101).

PMf~

neutrophils, by disruption of

They further stated that the inhibitory

effect of cytochalasin B on glucose oxidation was due to the fact that
cytochalasin B acts upon the cell membrane and thus inhibits transport
of glucose into the cell (35, 92, 101).
Showell, Kruetzer, Ward and others have demonstrated that interaction of chemotactic factors with cytochalasin B-treated cells (PMN
neutrophils) enhances release of lysosomal enzymes (7, 36, 70, 89).
Cytochalasin B reportedly acts by enhancing exocytosis (92).
Zurier et

~reported

that prior treatment of PMN neutrophils with

cyclic nucleotides, prostaglandin E1 or with compounds that interfere
with microtubule function (e.g. Vinblastin and Colchicine), blocked
enzyme release (101).

Henson

et~

showed that lysosomal enzyme release
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was inhibited by diisopropyl fluorophosphate and agents that increase
intracellular concentration of cAMP (35).
Ward confirmed the inhibitory effects of steroids, hydrocortisone
and methyl prednisolone (anti-inflammatory drugs), on chemotaxis of glycogen-induced rabbit peritoneal neutrophils (83).

He showed that

chloroquine, hydrocortisone and corticosteroids have a direct effect on
PMN neutrophils rendering them incapable of responding to a chemotactic
stimulus (25, 83).
Aspirin, a non-steroidal anti-inflammatory drug (85, 92) apparently
has no suppressive effect on chemotaxis.

However, aspirin appears to

suppress inflammation by blocking prostaglandin synthesis (85, 92).

Disorders of Neutrophil Chemotaxis
The discovery of syndromes involving defective neutrophil chemotaxis leading to increased susceptibility to bacterial infections adds
strength to the arguments in favor of the essential role of chemotaxis
in infections.

One example of such syndromes is chronic granulomatous

disease of childhood.

It is characterized by recurrent, severe bacterial

infections, dermatitis and chronic suppurative and granulomatous lymphadenitis (51, 57, 85, 96).
In Chediak-Higashi syndrome, a familial leukotactic defect, children
show defective neutrophil migration (18, 25, 60, 85).

This syndrome is

characterized by defective bactericidal activity in the presence of
normal ability to ingest bacteria, partial occulomatous albinism, and
a history of recurrent severe pyogenic infections.

The presence of ab-

normal giant cytoplasmic lysosomal granules is inherent of the defective
neutrophils.
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In 1971, Miller

et~

reported two children with depressed neutro-

phil mobility and recurrent infection.
"Lazy-Leukocyte-Syndrome'' (57).

This syndrome was termed the

This syndrome is characterized by

gingivitis, stomatitis and recurrent upper respiratory tract infections.
The patients' neutrophils demonstrate normal capacity for phagocytosis
and bacterial killing with abnormal membrane receptors for chemotactic
factors.
In diabetes melitus, neutrophils show a partially-defective chemoThis defect was corrected .i.!!. vitro by addition of

tactic response.

insulin and potassium to the neutrophil suspension (60, 86) .
Apart from the development of a new technique for measurement of
leukocyte chemotaxis by Boyden (14); interest in chemotaxis has soared,
because of the recognition of chemotactic defects in certain patients
with chronic bacterial infections.
Mowat

et~

were the first to report evidence that severe infections

may depress leukocyte function (60).

They showed that neutrophils of

patients with overwhelming bacterial infections, including tuberculosis
infections, were less chemotactically responsive than neutrophils from
healthy individuals.
In 1969, Ward -et -al reported that a child who was subject to frequent gram negative bacterial infections had an inhibitor of human
neutrophil chemotaxis in his serum.

This inhibitor appeared to act

directly on neutrophils, but did not affect the chemotactic stimulus
(27).

Ingham

et~

reported that serum reacted

with~·

fragilis

~laninogenicus was able to inhibit phagocytosis and killing of

or~
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Proteus mirabilis by PMN neutrophils in vitro (38) .
Defective neutrophil chemotaxis has been frequently associated
with juvenile periodontitis (18, 80).
In 1974, Boxer et

~described

a male infant with repeated bacterial

infections and a poor..:!.!!. vivo inflammatory response in affected tissues
{13).

Their..:!.!!. vitro studies demonstrated defects in PMN chemotaxis and

phagocytosis but enhanced degranulation (13).
The only report concerning the effect of bacteria and their products
on the migration of leukocytes was made by Martin and Chaudhuri (15).
They stated that purified gram negative bacterial product (Typhoid somatic carbohydrate) and whole Salmonella typhi (6xl0 6 org/ml) but not
staphylococcus or pneumococcus inhibited the migration of human PMN
neutrophils suspended in plasma (15).
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MATERIALS AND METHODS
Bacterial Strains
Bacteria used in this study were obtained from Virginia Polytechnic
Institute and State University (VPI), Blacksburg, Virginia.
species of Bacteroides used were Bacteroides fragilis
(ATCC 23745), VPI 2553 (ATCC 25285TI
vulgatus

[YPI 4245 (ATCC 8482]

thetaiotaomicron

The three

[YPI 9032, VPI 5383

clinical isolates, Bacteroides

a fecal isolate, and Bacteroides

('YPI 5482 (ATCC 29184~

a fecal isolate.

Stock cultures were maintained after growth for 24 hours at 37oc,
at room temperature under oxygen-free co 2 in pre-reduced chopped-meat
broth {Appendix B).

Preparation of Bacterial Chemotactic Factor
The defined medium used in preparing the bacterial factor was a
modification of the medium of Varel and Bryant (75).

It contained per

liter of distilled water:

glucose, 5g; (NH4)2S0 4 , lg; KH 2P04, 0.9g;
NaCl, 0.9g; CaC1 2 .2H 20, 26.5mg; MgC1 2 .6H 20, 20mg; MnC1 2 .4H 20, 20mg;
FeS04.7H 20, 4mg; CoC1 2 .6H 2o, lmg; resazurin, lmg; and Vitamin B12• lOµg.
The medium was adjusted to pH 6.5 with NaOH and sterilized at 1210C for
15 minutes .

To this medium, 20ml of sterile 25% (wt/vol) cysteine-HCl

and 50ml of sterile 8% (wt/vol) Na 2co 3 (each prepared in o2-free water
and kept under an atmosphere of C02) were added asceptically under oxygen
free co 2 .

Under oxygen-free co 2 , ?ml aliquots of the medium were dispensed into tubes and autoclaved in a press at 121°c for 15 minutes.
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One half ml of stock culture of organisms was transferred by pipette
into a ?ml tube of Varel and Bryant's modified defined medium under

o2-free co 2 and this culture was incubated at 37°c for 24 hours. The
culture was centrifuged at 5000 x g for 30 minutes.

The supernatant

was carefully removed with a sterile pipette and then filter sterilized
by passing the culture supernatant through membrane filters, 0.45µm
pore diameter (Millipore Corporation, Bedford, Massachusetts).

The con-

centrated cell suspension left in the tube of medium was checked for
contamination.

The sterile culture filtrates were stored at -20°c until

used.

Extraction of Bacteroides Lipopolysaccharide (LPS)
Lipopolysaccharide was extracted from Bacteroides fragilis VPI 9032
by the hot water-phenol extraction method of Westphal (37).

1) Two tubes containing 25ml of Trypticase Yeast Extract Glucose
(TYG) medium containing per liter of distilled water:

Trypticase, lOg;

Yeast extract, lOg; resazurin (25mg per lOOml of distilled water), 4ml;
salts solution, 40ml; glucose, lOg; hematin (50mg hemin in lml of lN
NaOH, add 99 ml

of distilled water), lOml; adjusted to pH 7.0, were

each inoculated with 0.5ml of stock chopped-meat culture of Bacteroides
under o2-free co 2 and grown overnight at 37°c.
2) Fifty milliliters of an overnight TYG culture was added per
liter of TYG which was then incubated for 24 - 48 hours.
3) The bacterial cells were harvested by centrifugation at 12,000 x g
for 10 minutes, washed 2x with 0.9% normal saline and frozen (-20°c).
4) Cells (25g, wet weight) harvested from 10 liters were dried in
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the following manner:

a.

150ml of 95% ethanol (4°C) were added to the cells with
stirring and the mixture was centrifuged at 12,000 x g
for 10 minutes at 4°C.

b.

150ml of acetone (4°C) was added to pellet.

The pellet

was resuspended then centrifuged at 12,000 x g for 10
minutes at 4°c.
c.

The resulting pellet was resuspended in 150ml of diethyl
ether (4°C) and centrifuged at 10,000 x g for 10 minutes
at 4°c.

5) The dried cells (approximately 5g) were pulverized and dried
in a vacuum dessicator to a constant weight.
6) 5g of dried bacteria were suspended in 70ml of distilled water
in a 68°C water bath.
7) 70ml of 90% (wt/vol) phenol (preheated to 68°C) were added with
vigorous stirring.

This was incubated for 30 minutes at 68°C with inter-

mittent agitation, then cooled to about 10°c in an ice bath.
8) The mixture was centrifuged at 8,000 x g for 45 minutes, and the
upper layer (which contains lipopolysaccharide, nuclei acids and polysaccharides) was aspirated off.
9) To the phenol layer and insoluble residue, 70ml of water (68°C)
were added, stirred and heated to 680C for 30 minutes.
10) The mixture was cooled to 10°c in an ice bath and Step 8 was
repeated.
11) The combined aqueous layers were dialyzed against distilled
water for three days with numerous changes of water to remove the phenol.
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12) The volume was reduced to about 14ml by reduced pressure
evaporation at 40°C.
13) This was centrifuged for 15 minutes at 3,000 x g at 4°C and the
pellet was discarded.
14) The supernatant was lyophilized and this was designated crude
lipopolysaccharide (LPS).
15) The crude lipopolysaccharide was resuspended in distilled water
(3g per lOOml) and centrifuged 105,000 x g for four hours.

The pellet

was resuspended in distilled water and centrifuged (105,000 x g for
four hours) twice more.
16) The pellet was resuspended in distilled water and centrifuged
at 3,000 x g for 10 minutes and the pellet was discarded.
17) The supernatant was lyophilized.

Preparation of Crude Bacteroides outer membrane (40, 43).
Under oxygen-free co 2 , two tubes containing 25ml Trypticase Yeast
Glucose (TYG) medium, were innoculated with 0.5ml of stock chopped-meat
culture of Bacteroides and grown overnight at 37°c.

Fifty milliliters

of an overnight TYG culture of Bacteroides was added per liter of TYG.
This was allowed to grow for 24 - 48 hours at 37oc.
checked for contamination.

All cultures were

Organisms were pelleted by centrifugation at

12,100 x g for 20 minutes and then washed 2x in 0.05M phosphate buffer.
Pelleted organisms were suspended in a buffer containing:

0.05M sodium

Phosphate, 0.15M NaCl and O.OlM EDTA, and adjusted to pH 7.4 at 24°C
(the final volume was about 1/50 of original culture).

The cell suspen-

sion was incubated at 6ooc for 30 minutes and then passed through a 25gauge hypodermic needle, after which the suspension was mixed for 10
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seconds in a Waring Blender.

Organisms were pelleted from this suspen-

sion by centrifugation at 12,000 x g for 20 minutes at 4°C.
natant was centrifuged at 80,000 x g for two hours at 4°C.

The superThe pellet

(crude outer membrane) was lyophilized (freeze dried).

Rabbit Peritoneal Exudate Cells
The procedure used for harvesting rabbit peritoneal polymorphonuclear neutrophils (PMN) is similar to that employed by other investigators (22, 70).

Adult New Zealand White Rabbits (Glouchester Rabbitry,

Chepachet, Rhode Island) were injected intraperitoneally with lOOml of
sterile 0.1 % (wt/vol) glycogen in isotonic saline.

Four to seven hours

later, lOOml of sterile heparinized-saline (5 units

heparin/ml) were

introduced into the peritoneal cavity.

The peritoneal exudate was with-

drawn via 16 gauge canula into plastic containers by gravity drainage.
These rabbits had been repeatedly primed with 0.1 % glycogen in saline to
produce large numbers of exudate cells prior to their use in these experiments.

Rabbits were not injected with glycogen-saline more than

once in every three weeks.

Any contaminating erythrocytes in peritoneal

exudates were lysed with NH 4c1, pH 7.3, and exudates contaminated with
large amounts of erythrocytes were discarded. The rabbit peritoneal
exudates were centrifuged in plastic tubes at 1,000 x g for five minutes
at 4°C.

Pelleted peritoneal PMN neutrophils were washed twice with at

least 30ml of sterile normal saline.

A concentrated cell suspension of

the peritoneal PMN neutrophils was made in saline.

Wright stained

smears and wet mount differential counts revealed that this suspension
contained 98% PMN neutrophils.

Appropriate dilutions of the concentrated

cell suspension were made in Hank's balanced salts solution (HBSS)
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containing 0.05% (wt/vol) Bovine serum albumin.

For chemotaxis assays

2.5 x 10 6 cells/ml were employed whereas 1 x 10 7 cells/ml were routinely
used for enzyme release assays.

Chemotaxis Chambers
Modified Boyden Chambers with steel housing were used for Chemotaxis
experiments.

The chambers were assembled with a 25mm coverslip; a soft

silicone rubber gasket (25mm outside diameter and 19mm inside diameter);
pre-tested membrane filter, 25mm diameter, 0.8µm porosity, and 150µm
thick; another gasket; a 25mm coverslip again, and then closed with a
screw top.

The chamber was thus separated into an upper and a lower com-

partment with a membrane filter separating the two compartments.

The

lower chamber was loaded by injecting the material (about 0.8ml) tested
for chemotactic activity or HBSS with a tuberculin syringe (26 gauge
needle) through one of the ports at the side of the Boyden chamber.

While

filling the compartment, a needle was placed in the opposite port to allow
air to escape.

The material in the lower compartment was allowed to

diffuse through filter to the upper compartment of the filter to produce
a concentration gradient.

A lml aliquot of rabbit peritoneal PMN neutro-

phils was placed in the upper compartment of each Boyden chamber.

When

bacterial products (culture filtrates, outer membrane and LPS) were
tested for ability to induce random locomotion (chemokinesis)/or directed
migratory response (chemotaxis), they were added to both the upper and
lower compartments in varying concentrations, in keeping with the method
described by Zigmond and Hirsch (100).

All filters used in this study

were from one batch, tested and proven membrane (Pathology Department,
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University of Connecticut, Health Center, Farmington, Connecticut).
This incubation period was chosen because upon testing the membrane
filters, the greatest difference between the number of cells moving into
the filter with no chemotactic stimulus in the lower compartment (background) and the maximum number of cells moving into the filter in response to a chemotactic attraction from the lower compartment was found
after one hour incubation.

Duplicate chambers were incubated at 37°C

for 60 minutes.

Polymorphonuclear Neutrophil Chemotaxis Measurement
Modified Boyden Chambers were disassembled after the appropriate
incubation period.

A procedure similar to that of Boyden (14) was used

to process the membrane filters.

A brass cassette (Schleischer and

Shuell) which permits simultaneous staining of 25 filters was used to
facilitate this process.

Micropore filters removed from dismantled

chambers were quickly immersed in 100% isopropyl alcohol and fixed for
3 minutes.

The cells on the filters were stained as follows:
a.

Erhlich's hematoxylin 6 - 10 minutes.

b.

Rinsed in distilled water 30 seconds.

c.

Blueing agent (20g MgS0 4 , 2g NaHco 3;1 liter of distilled
water) 6 - 10 minutes.

d.

Rinsed in distilled water 30 seconds.

e.

Dehydrated in 70% isopropyl alcohol, two minutes.

f.

95% isopropyl alcohol, two minutes.

g.

100% isopropyl alcohol, two minutes.

h.

100% isopropyl alcohol again, two minutes.

i.

Filters were cleared in xylene.
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The filters were mounted on microscope slides with permount (Fisher
Scientific Company, Pittsburg, Pennsylvania).

The high power objective

(40X) and lOx ocular of a microscope were used to count the cells;
while the micrometer of the fine adjustment was used to measure the
distance from the top of the membrane filter to the farthest plane of
focus still containing two cells.

This distance was measured for at

least three random (ocular grid) fields.

Duplicate chambers were

assayed and the data represent the mean measurements of the two membrane
filters examined.

Increases in distance travelled into the membrane

filter of lOµm above negative control by PMN neutrophils migrating
toward an attractant are statistically significant (25).
The Chemotactic Index (CI, the average distance that cells migrate
in one hour at 37°C) was calculated in the following manner:
Cells in focus were counted at each lOµm from original
monolayer to the distant plane of the membrane filter.
The number of cells counted per level was multiplied by
the distance (in µm) of that level from the starting monolayer.

The sum of the products obtained was divided by

the total number of migrated cells.

Chemotactic Factor Derived From Human Complement 5th Component (C5fr)
The purified C5ff was supplied by Donald L. Kreutzer of the
University of Connecticut Health Center, Farmington, Connecticut.

The

chemotactically active C5fr were stored at -20°c in 0.5ml aliquots.
The solution was thawed before use and 1.5ml of 0.5M dibasic sodium
Phosphate pH 7.2 - 7.4 was added.

Chemotactic activity of the C5fr.·
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was normalized by determining the quantity of C5fr that produced 50%
of the maximal chemotactic response in Boyden Chambers (22).

Three

times this quantity of C5fr was used to assure consistent maximum
chemotaxis and enzyme release from one cell preparation of polymorphonuclear neutrophils to another.

Induced Lysosomal Enzyme Release
The ability of Bacteroides products, C5fr,

Varel and Bryant's

defined medium, and HBSS buffer to trigger the release of N-acetyl-SD-glucosaminidase from rabbit peritoneal PMN neutrophils was assayed
by an adaptation of the Method of

Wollen~~

(3).

p-nitrophenyl

N-acetyl- S-D-glucosaminide was the substrate for determining amount of
enzyme released.
Washed rabbit peritoneal exudate cells were suspended at a final
concentration of 1 x 10 7 cells/ml in Hanks balanced salts solution containing 0.05% (wt/vol) Bovine serum albumin.

One µg of a stock solution

(4mg per ml, in dimethyl sulfoxide) of cytochalasin B (Sigma Chemical
Company, Milwaukee, Wisconsin) was added per ml of cell suspension.
Dimethyl sulfoxide has no effect on the enzyme release response (70).
Cells, samples tested, and tubes used in these experiments were all
equilibrated at 4°c, except where otherwise stated.

One-half milliliter

of cell-cytochalasin B suspension was quickly added to 50µ1 of test
material ~nown chemotactic factor (C5fr), buffer (HBSS), or bacterial
producf} in plastic tubes.

The mixtures were incubated for five minutes

in a 37°c gyrotory water bath shaker.

Release is completed in one minute

or less under these conditions (70).

Tubes were centrifuged at 2,000 x g
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for five minutes at 4°C.

The cell supernatants were transferred to

clean tubes for assay of N-acetyl- S-D-glucosaminidase activity.

Aliquots

of these supernatants were kept (at 4°C) for measurement for lactate
dehydrogenase.

Cell pellets were discarded.

N-acetyl- S-D-glucosaminidase Assay
Equal volumes (0.5ml) of freshly prepared p-nitrophenyl N-acetylS-D-glucosaminide (1.4mg per ml in 0.05M sodium citrate . buffer, pH 4.5)
and cell supernatant were mixed by vortex.

Mixtures were incubated at

37oc in a gyrotory shaking water bath for one hour.

Following incuba-

tion 0.5ml of glycine buffer (0.4M, pH 10.5), was added to the mixture
to stop the reaction.

p-Nitrophenol (a yellowish colored compound) was

liberated from the substrate in the presence of N-acetyl-S-D-glucosaminidase.

Absorbance was read at 410nm in a Gilford spectrophotometer.

Positive (C5fr) and negative (HBSS) controls were included with each
assay.

Additional control mixtures containing only bacterial products

were employed to demonstrate that these bacterial products had no
glucosaminidase activity.

All tests were performed in triplicate.

Lactate Dehydrogenase (LOH) Assay
Bacteroides products were assayed for the ability to trigger lysis
of the peritoneal exudate cells and release lactate dehydrogenase (a
cytoplasmic enzyme) from rabbit peritoneal neutrophils according to the
method in Biochemical Information (11).

This is a standard assay which

measures the oxidation of reduced nicotinamide adenine dinucleotide
(NADH) during the reduction of pyruvate to lactate.

1

NAO+

r~-0
lH 3

NADH~

lactate dehydrogenase )
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rooHO-r-H

~H3
L - lactate

Pyruvate
The reaction mixture contained:

2.83ml of O.lM phosphate buffer,

pH 7.0 (530mg KH 2Po 4 + 1.39g K2HP0 · 3H 20/100ml, cooled at 4°c in an
4
ice bath); O.lml of 23mM sodium pyruvate solution (25mg sodium pyruvate/
lOml, cooled to 4°C in an ice bath); and 0.05ml of 12mM NADH solution
(lOOmg NADH, Na 2 - salt/lOml, cooled to 4°c in an ice bath).
The enzyme reaction was initiated by addition of 0.02ml of cellfree supernatant. Absorbance at 340nm (A 340 ) was read after one, two,
three, four and five minutes.

Change in A340 per minute (6A340) was
used to report the level of lactate dehydrogenase activity. All assays
were performed in triplicate.

Reagents
Cytochalasin B, p-nitrophenyl- S-0-glucosaminide, and guinea pig complement were obtained from Sigma Chemical Company, Saint Louis, Missouri.
All other reagents used in this study were of analytical grade.
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RESULTS
Induction of PMN Locomotion
The crude outer membrane (OM) of Bacteroides fragilis (VPI 5383)
was assayed at various concentrations to determine possible chemotactic
activity for PMN neutrophils.

The response of rabbit peritoneal PMN

neutrophils was positive for locomotion, and the level of response was
dependent upon the amount of OM added (Figure 1).
filtrates (CF)

of~·

fragilis (VPI 9032)

and~·

Cell-free culture

thetaiotaomicron (VPI

5482) showed a similar positive chemotactic response to increasing doses
(50µ1 to 150µ1).
Bacteroides were cultured in a defined medium formulated by Varel
and Bryant (75).

Table 1 gives the results for the positive and nega-

tive controls included in the chemotaxis experiments employing Boyden
chambers.

The buffer, Hank's balanced salt solution (HBSS), gave no

locomotion of PMN neutrophils; nor did several concentrations of fresh
sterile Varel and Bryant defined minimal medium.

The positive control,

activated C5 fragment of serum complement, always elicited positive
chemotaxis; demonstrating that the rabbit PMN neutrophils used in the
assay were indeed responsive to chemotactic stimuli.

Chemotaxis versus Chemokinesis
Figure 2 demonstrates the response of rabbit PMN neutrophils to
B. vulgatus (VPI 4245) OM was indeed Chemotactic (locomotion directed
toward a concentration gradient).

When concentrations of 50 to 150µg
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of OM were added to the lower compartment, movement toward the lower
compartment increased.

When 50µg of OM were added to the upper com-

partment movement of PMN neutrophils was only observed when the concentration of OM in the lower compartment was above 50µg.

When the OM

concentration in the upper compartment was increased to lOOµg, downward
movement of the PMN neutrophils was only observed when the OM concentration in the lower compartment exceeded lOOµg.

Finally when the upper

compartment contained 150µg of OM, there was no movement of the PMN
neutrophils toward the lower compartment .

Interaction of Bacteroides Cellular Components or Products with Rabbit
PMN Neutrophils.
Lipopolysaccharide (LPS), CF and OM of!!_. fragilis showed some
chemotaxis of rabbit PMN neutrophils (Table 2).

The activity of the

LPS of!!_. fragilis (VPI 9032) was increased significantly by pre-incubation with guinea pig complement at 37°c for 30 minutes; while the CF
and OM gave a very negative reaction with PMN neutrophils after preincubation with guinea pig complement (Table 2).

There appeared to be

an inhibitor of chemotaxis produced when CF or OM was pre-incubated
with guinea pig complement.
When the purified C5 fragment of complement was reacted with CF or
OM, the chemotactic response of PMN neutrophils was significantly reduced; however, not back down to the negative control level (Table 3).
When the amount of OM (VPI 5383) was increased to 62 . 5µg/ml, the chemotactic activity of the C5 fragment was completely abolished.
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J.!lduction of Exocytosis of N-acetyl- B-glucosaminidase from Cytochalsin
B-treated Rabbit PMN Neutrophils by Bacteroides Cellular Components or
Products.
Culture filtrate

of~·

fragilis (VPI 2553 and VPI 5383) and!!_.

vulgatus (VPI 4245) caused a slight exocytosis of N-acetyl- B-glucosaminidase (Table 4).

The LPS of!!_. fragilis (VPI 9032) and OM (VPI 2553,

VPI 5383 and VPI 9032) did not cause any significant exocytosis (Table 4).
However, when the CF, LPS or OM were pre-incubated with guinea pig
complement at 37°c for 30 minutes, they released as much or more N-acetyl8-glucosaminidase activity from the cytochalasin B-treated neutrophils
as the CS fragment (Table 5).

No significant difference was observed

when the guinea pig complement was added to the reaction mixture and
assayed without pre-incubation.

When the guinea pig complement was heat-

inactivated (ss 0 c for 30 minutes) prior to mixing Bacteroides cellular
components or products, the exocytosis response was reduced by about
one-half.

When these cellular components or products of Bacteroides were

incubated in the reaction mixture, in the absence of PMN neutrophils, no
color developed; indicating that the bacteria had no N-acetyl- B-glucosaminidase activity.

Furthermore, no detectable level of lactate dehydro-

genase could be measured in the positive exocytosis reaction mixtures;
indicating that PMN neutrophil lysis was not required for the release
of N-acetyl- B-glucosaminidase, because lactate dehydrogenase is only
found free in the cytoplasm of PMN neutrophils.
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Fig ure 1.

Dose response of rabbit PMN neutrophils

to Ba cteroides fragilis (VP! 5383) outer membrane
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Table 1.

Chemotactic Response of Rabbit PMN

Neutrophils to the Defined Medium of Varel and Bryant
Chemotactic Activit

Additions to

(d

Lower Com artment
Dept =

(c)

PMN neutro hils/2HPF (mean ± sd)
lOµm

Chemotactic Index

30µm

40µm

0

0

0

10.0

Varel and Bryant
(a)
Defined Medi um: · 50µ1 12±2.1

0

0

0

10.0

100µ1 11±2 .1

0

0

0

10.0

150µ1 15.5±0.35 0

0

0

10.0

20.5±4.2

None (HBSS)

C5 fragment, 30µ1
(Positive Control)

31±3.0

18.5
±3.8

3.5
±0.95

0.25(b)
±0.25

14.8

a)

Each concentration of Varel and Bryant defined medium was added to
HBSS (0.8 ± 0.2ml) in lower compartment

b)

Value not included in calculating Chemotactic Index (average distance
traveled per neutrophil), because leading front cells were less than
2.

c)

The Chemotactic Index is the average distance (in µm) the PMN neutrophils have penetrated into the membrane filter in one hour at 37°c.

d)

The values represent the mean cell count (± sd) in two high power
fields for duplicate chambers.
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Figure 2.

Locomotion of Rabbit PMN Neutrophils in

Established Gradients of Bacteroides vulgatus VPI 4245 outer membrane

PMN

A.

Chemokinesis
H. P.F. (mean ± SEM)(a)

Neutro~hils/4

Concentration (µg/ml)
of OM 4245
Above Filter

Concentration of OM 4245
Bel ow Filter
0

50

0

100

150

46.3( ±9.4)

47.5( ±5.2)
40.3( ±8.5)

50
100

3.0( ±1.7)

150

2.8( ±1.7)

8.0( ±4.5)

Chemotactic Index(b)

B.
Concentration (µg/ml)
of OM 4245
Above Filter

Concentration of OM 4245
Below Filter
50

0

50

10.0

100

10.0

10.0

150

10.0

10.0

100

150

10.92

11.89
10.50

10.0

a)

Values represent the mean (± SEM) number of neutrophils per
high power (400x) field [four high power fields were counted for
duplicate Boyden chamber]) .

b)

The values represent the average distance (µm) traveled per neutrophil
from the top of the filter toward the bottom.
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Table 2.

Rabbit PMN Ne utrophils Response to Bacteroides

fragilis Cellular Components or Products in the Presence
and Absence of Guinea Pig Complement

Addition to
Lower Compartment

Chemotactic Activity
(a)
PMN Neutrophils/4
Chemotactic
Index
H.P.F. (mean ± SEM)

None (HBSS)

58±3.9

10 .0

Culture filtrate (CF) VPI 5383(c)(50µl)(b)

257±4.4

12 .14

Lipopolysaccharide (LPS) VPI 9032
(62.5µg)

66±4 .9

11.17

Outer membrane (OM) VP! 2553 (62.5µg)

62.5±7.0

10.94

Outer membrane (OM) VP! 5383 (6 2.5µg)

83±4.2

11.20

Outer membrane (OM) VP! 9032 (62 .5µg)

88±19.3

12.29

CF VP! 5383 +Guinea pig comp . (37°c)(b)

18. 5±13 . 1

10 . 0

LPS VP! 9032 + Guinea pig comp. (c) (37°c)

75.8±14.4

13.27

OM 2553 + Guinea pig comp. (c) (37°c)

53.3±6.4

10 .0

OM 5383 + Guinea pig comp. (c) (37°c)

24.3±1.4

10.0

OM 9032 + Guinea pig comp. (c) (37°c)

10.0±7 . l

10.0

C5fr (30µ1 , Positive Control )

152±11.5

13 . 56

a)

Chemotactic Index is the average distance {µm) traveled per neutrophil
from the top of the filter toward the bottom.

b)

These were from another exper iment having control values of 17.3±3.1
PMN neutrophils /4 H.P.F. ± SEM and 10 .0 Chemotactic Index for no
additions and 394±39.6 PMN neutrophils/4 H.P.F. ± SEM and 17.06
Chemotactic Index for 30µ1 of C5fr (in 0.8 to lml HBSS) .

c)

lml of culture filtrate or lml of HBSS containing 62.Sµg OM or LPS was
added to lml of guinea pig complement and incubated at 37°C for 30
minutes. 0.8 to 1.0 ml of one of these mixtures was added to the
l O\~er compa rtment of the Boyden chambers .
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Table 3.

Rabbit PMN Neutrophils Chemotactic Response

to C5 Fragment in the Presence and Absence of Bacteroides
fragilis VPI 5383 Cellular Components or Products

Addition to
Lower Compartment

Chemotactic Activity
PMN Neutrophils/4
Chemotactic
H.P.F. ± SEM
Index

None (HBSS)

17.3±2.2

10.0

C5fr (30µ1)

394±28.0

17.06

Culture filtrate (CF) VPI 5383 (50µ1)

257 ±4.4

12.14

Outer membrane (OM) VPI 5383 (62.5µg)

237 ±13.8

12.83

CF VPI 5383 + C5fr(a)

313±23. 4

14.29

OM VPI 5383 + C5fr(a)

301±49.8

14.6

a)

One ml of CF or HBSS containing (62.5µg/ml) OM was added to lml of
HBSS contain i ng 30µ 1 of C5fr. This was incubated at 37°c for 30
minutes, then 0.8 - 1 ml of the mixture was added to the lower compartment of Boyden chambers.
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Table 4.

N-acetyl- 8-glucosaminidase Activity(a) Released

From Cytochalasin B-treated Rabbit PMN Neutrophils in
Response to Cellular Components or Products of Bacteroides

Additions to Reaction Mixture(b)
None

(0.587±0)

C5fr (50µ1, positive control)

0.993±0

Culture Filtrate VPI 2553

0.093±0.004

Culture Filtrate VPI 4245

0.114±0.01

Culture Filtrate VPI 5383

0.080±0.005

Lipopolysaccharide VPI 9032

0.040±0.01

Outer membrane VPI 2553

0.043±0.12

Outer membrane VPI 5383

0.043±0.04

Outer membrane VPI 9032

0.046±0.06

a)

The reaction mixture contained: 0.5ml of 4mM solution of p-nitrophenyl - N-acetyl- 8-glucosaminide in 0.5M sodium citrate (pH 4.5),
and 0.5ml of test sample. The mixture was incubated at 37°C for
one hour, then terminated by addition of 0.5ml of 0.4M glycine
buffer (pH 10.5) and the absorbance at 410 nm was read in a spectrophotometer.

b)

The reaction mixture contained: 0.5ml of cytochalasin B-treated
rabbit PMN neutrophils (5 x 10 6 cells), and 0.05ml of sample (CF or
HBSS containing 62.5µg/ml of OM or LPS). The mixture was incubated
for five minutes at 37oc, centrifuged at 2000 x g for five minutes,
and the supernatant was assayed for N-acetyl- 8-glucosaminidase.
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Table 5.

N-acetyl- S-glucosaminidase Activity Released From Cytochalasin

B-Treated Rabbit PMN Neutrophils in Response to Bacteroides Cellular
Products or Components Pre-Incubated at 37°c with Guinea Pig Complement
for 30 minutes(a)
Addition to Reaction Mixture
None

0.587±0

C5fr (50µ1, Positive Control)

0.993±0

Culture Filtrate VPI 2553

1.044±0.045

Culture Filtrate VPI 4245

1.282±0. 24

Culture Filtrate VPI 5383

1.251±0.29

Lipopolysaccharide VPI 9032

1.096±0.07

Outer membrane VPI 2553

1.473±0.06

Outer membrane VPI 2553

1.276±0.04

Outer membrane VPI 9032

1.219±0. 04

Refer to Table 4 for assay procedure.
a)

lml of CF or HBSS containing (62.5µg/ml) of OM or LPS was added to
lml of guinea pig complement and incubated for 30 minutes at 37oc,
prior to adding 50µ1 of this mixture to the cytochalasin B-treated
PMN neutrophils.
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DISCUSSION
The observations reported here indicate that both outer membranes
and culture filtrates of Bacteroides fragilis

(VPI 5383, VPI 9032, VPI

2553) and B. vulgatus (VPI 4245) induced PMN neutrophil chemotaxis.
Furthermore, when guinea pig serum complement was incubated with outer
membranes or culture filtrates of.!!_. fragilis (VPI 2553, VPI 5383, VPI

9032) or.!!_. vulgatus (VPI 4245) or the lipopolysaccharide of.!!_. fragilis
(VPI 9032), the release of N-acetyl- 8-glucosaminidase from cytochalasin
B-treated PMN neutrophils was induced.
In contrast, PMN neutrophil chemotaxis was markedly diminished
when Bacteroides crude outer membrane or culture filtrates were preincubated (at 37°c for 30 minutes) with guinea pig serum complement.

These

findings suggest that an inhibitor of neutrophil chemotaxis may be generated upon interaction of Bacteroides outer membrane or sterile culture
filtrates with guinea pig complement.

The fact that this factor (or

inhibitor of neutrophil chemotaxis) was able to increase enzyme release
of PMN neutrophils; while at the same time inhibit chemotaxis, suggests
that either different PMN neutrophil receptors were triggered or the
neutrophil receptors responsible for chemotaxis inhibition and enzyme
release are identical or situated in the same vicinity, such that once
one receptor is triggered the other is also.
Casciato et al indicated that different metabolic pathways may be
involved in neutrophil movement, depending upon the mechanism that
produced the chemotactic factor (17).

Whereas chemotaxis in response
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to factors produced by whole Staphylococcus aureus, Escherichia coli
and!· fragilis suspended in plasma was depressed under anaerobic conditions, chemotaxis induced by factors generated from immune complexes
suspended in plasma was identical under aerobic and anaerobic conditions
(17).

Hence, they suggested that suspension of bacteria in plasma might

have produced an inhibitor of neutrophil chemotaxis.

Indeed, inhibitors

of chemotaxis produced by soluble products, purified Typhoid somatic
carbohydrate (15), bacterial toxins liberated from S. aureus (93) and
Clostridium perfringens (97) have been demonstrated.
The factor produced when Bacteroides cellular components or products (outer membrane and culture filtrates) were incubated with guinea
pig complement may have induced a shock effect on the neutrophils, resulting in inhibited locomotion or altered inflammatory response;
mimicking the Leukopenia evidenced in the
endotoxin.

j__Q_

vivo response to bacterial

This possible relationship was previously discussed by

Martin and Chaudhuri (15).
Previous studies dealing with interactions of synthetic peptides
and neutrophils suggested that there may be a common receptor for chemotaxis, lysosomal enzyme secretion from neutrophils and phagocytosis (45,
70).

Our findings do not necessarily contradict the previous studies;

however, the data indicates that the two neutrophil functions, inhibited
locomotion and enzyme release, may be triggered by the same factor
generated upon incubation of Bacteroides outer membrane or culture
filtrates with guinea pig serum complement.
This report demonstrates that Bacteroides LPS, outer membrane and
culture filtrates possess low chemotactic activity and enzyme releasing
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effect on neutrophils in comparison with the C5 fragment.

This agrees

in part with earlier findings by Sveen and others who showed Bacteroides
LPS possesses chemotaxigenic activity for leukocytes (77, 78).

Our find-

ings also support the report that the interaction of Bacteroides LPS
with serum complement leads to increased neutrophil chemotaxis (77, 78);
thus demonstrating Bacteroides LPS is cytotaxigenic.
that:

Our data showing

(i) Bacteroides outer membrane and culture filtrates induce low

level chemotaxis and enzyme release; and (ii) incubation of the same
Bacteroides cellular components or products with guinea pig complement
resulted in increased enzyme secretion and retarded neutrophil locomotion,
add credence to the suggestion that different receptors are involved in
PMN neutrophil locomotion and enzyme release (in response to Bacteroides
cellular components or products).

Another possibility might be that the

neutrophil receptor sites responsible for positive chemotaxis, inhibited
chemotaxis, and enzyme release are topographically closely linked or
identical.
Chemokinesis experiments demonstrated a requirement for Bacteroides
cellular components or products to establish a concentration gradient
across the Millipore membrane filter before neutrophil chemotaxis could
take place.

This indicates that the Bacteroides cellular components and

products tested were truly chemotactic for neutrophils, and were not
simply inducing random walk (chemokinesis) of the neutrophils.

These

findings agree with those of Casciato~~ (17), Zigmond and Hirsch (100)
and others who have demonstrated that a concentration gradient is required for neutrophil chemotaxis.

Furthermore, according to these

investigators, it is essential (in describing any substance as being
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"chemotactic" on the basis of its ability to induce migration in Boyden
chamber) to provide evidence that the substance is capable of inducing
directed movement (70).
In this study, Bacteroides cellular components and products did
not induce the release of lactate dehydrogenase (LOH).

Lactate dehydro-

genase is strictly a cytoplasmic, non-lysosomal, enzyme; therefore, it
is a marker of cell viability (34-36, 99).

The lack of release of the

non-granular enzyme, lactate dehydrogenase, indicates that cell damage
was not necessary for extracellular release of the granular enzyme Nacetyl- S-glucosaminidase.

Also, in the absence of neutrophils,

Bacteroides cellular components and products had no N-acetyl- S-glucosaminidase activity.
When guinea pig serum complement was heat-inactivated

(ss 0 c for

30

minutes) and subsequently added to equal volumes of Bacteroides outer
membrane or culture filtrates, neutrophil chemotaxis was still reduced
and considerable enzyme release still occurred.

This indicates the pro-

inhibitor, or whatever factor it may be, that is produced when Bacteroides
cellular components or products are incubated with serum complement may
be heat stable.
Our results also indicated that when Bacteroides outer membrane or
culture filtrates were incubated with purified CS fragment, PMN neutrophil chemotaxis was decreased, relative to the response to the CS fragment alone.

However, the same Bacteroides cellular components or pro-

ducts pre-incubated (at 37°c for 30 minutes) with guinea pig complement
inhibited PMN neutrophil chemotaxis far more than when they were incubated with just the purified CS fragment.

This suggests that additional
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serum factors in guinea pig complement, which were absent from purified
C5 fragment, may be necessary for initiating inhibition of neutrophil
chemotaxis by Bacteroides culture filtrates and outer membrane.
Martin and Chaudhuri reported the only previous findings, that
leukocyte migration was inhibited by gram negative bacterial components
or products and they indicated that staphylococci and pneumococci were
without effect (15).

Bryant et tl presumed that the inhibition of neu-

trophil migration produced by gram negative cellular components or products reported by Martin and Chaudhuri was because gram negative bacterial
products contain smaller and more dispersable particles than gram positive
bacterial products.

These gram negative products, as presumed by Bryant

et tl, could be digested even in systems not designed to enhance cellparticle contact and thus lead to inhibition of neutrophil chemotaxis
(15).

This assumption appeared to be based on the technique used by

Martin and Chaudhuri (15).

However, the present study examined the inter-

action of Bacteroides cellular components and products with Boyden's
technique (14).
et~

Our data clearly contradict assumptions made by Bryant

and support the findings by Martin and Chaudhuri.

experiments with Boyden's technique are, according to

Chemotaxis

~Jard

et tl (85-91),

Zigmond and Hirsch (100), Kreutzer and Fantone (22), and Becker et tl
(6-9), not only qualitative but also quantitative .

This technique has

proved to be the most widely used and accepted because of its reproducibility (6).

However, it should be noted that many of these investigators

presently employ computers for determination of chemotactic counts, due
to the very tedious nature of counting chemotaxis slides.

In this study

manual counting was employed, hence it was usually necessary to have a
blind reading .
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A relationship was shown between the amount of outer membrane of
B. fragilis and the chemotactic response of rabbit peritoneal neutrophils
(Figure 1).

Ward, Lepow, and Newman previously demonstrated a direct

relationship between the amount of 48 hour culture filtrate from Type 3
pneumococcus and neutrophil chemotaxis (91). The slope of their line
was greatest at lower doses (50µ1 and 100µ1).

The data in Figure l,

indicates that the sharpest rise in neutrophil chemotactic response to
Bacteroides outer membrane was around 50 - 62µg/ml.

This was the reason

why 62.5µg/ml of either outer membrane or LPS were used routinely for
the chemotaxis and enzyme release experiments.
The incidence of anaerobic infections caused by gram negative
bacteria has increased in recent years and§._. fragilis is the organism
most frequently encountered in these human infections (29, 39-44, 53).
Bacteroides may act synergistically with other obligate anaerobes [eg.
Fusobacterium necrophorum (29, 312) in mixed infections to inhibit
phagocytosis and killing of other bacteria; which, when present alone
may not be virulent (29, 31, 38).

Ingham

et~

found that the inhibitory

activity of these obligately anaerobic Bacteroides is due solely to an
interaction with serum (38).

Our data agree with his findings and also

support his suggestion that there is need for study of the serum moiety
or moieties affected by Bacteroides.

The factor or effect produced by

incubating Bacteroides cellular components or products (outer membrane
and culture filtrates) with serum complement, behaves similarly to the
neutrophil-i mmobilizing factor described by Goetz and Austen (27).

The

neutrophil-immobilizing factor is a low molecular weight, heat-stable
substance liberated from neutrophils during maximum phagocytosis.

This
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immobilizing factor which inhibits neutrophil movement gives high yields
of lysosomal enzymes (27).
The high frequency

of~·

fraailis in clinical infections (31) has

been postulated to be due to the resistance of most strains
to antibiotics (29, 31, 53).

of~·

fragilis

Tissue damage occurs when neutrophils

release tissue destructive lysosomal enzymes into their surrounding
environment (34, 99).

These data indicate that in the presence of guinea

pig serum complement, enzyme release is increased and neutrophil locomotion is inhibited; interfering with phagocytosis.

These findings coupled

with the resistance of Bacteroides to antibiotics may well account for
the fact that a combination of antibiotic therapy and surgical drainage
of Bacteroides abscesses (71) is usually required for eradication of
these infections.

Furthermore, it is suggested that mixed flora infec-

tions due in part to Bacteroides may be attributed to the production of
PMN neutrophil inhibitor(s); since the Bacteroides products from different strains were capable of producing similar neutrophilic responses.
Little is known about cellular or whole body interaction with factors produced by bacteria (91, 96).

Two neutrophil-associated serine

esterases, one present as an active esterase the other as a proesterase,
are required for the interaction of complement-derived factor with neutrophil - to cause chemotaxis (91).

However, it is still not clear

whether these same esterases are required for the neutrophils to respond to bacterial chemotactic factors.
Bacteroides fragilis produces many extracellular substances and the
full array of extracellular enzymes produced by the genus Bacteroides
is not known (68).

Rudek and Haque have shown that Bacteroides produce
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fibrinolysin, penicillinase, lysozyme, lecithinase, deoxyribonuclease,
phosphatase, protease, gelatinase, lipase, elastase, chondroitin
sulphatase and hyaluronidase (68).

The roles of these enzymes in

Bacteroides infectious processes is uncertain.

In other bacteria (eg.

staphylococci), elastase, hyaluronidase and chondroitin sulfatase have
been suggested as invasive or spreading factors in the infectious process (68).
Further study concerning the response generated when serum complement and Bacteroides outer membrane or culture filtrates interact is
needed.

One should also examine the role played by extracellular enzymes

produced by Bacteroides.

The host defense mechanism(s) and the patho-

genicity of the infecting bacteria are important in bacterial infections;
hence, further study of the interaction of Bacteroides purified products
or cellular components may give a better understanding to the role
Bacteroides plays in human infections.
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APPENDIX A
Salts Solution (37a)
Add the following as described:
CaC1 2 (anhydrous)

0.2g

MgS0 4 (anhydrous)

0.2g

K HP0
2
4

l.Og

KH 2Po 4

l.Og

NaHC0 3

10.0g
2.0g

NaCl

Mix CaC1 2 and MgS0 4 in 300 ml distilled water until dissolved. Add
500 ml distilled water and while stirring, slowly add the remaining
salts.

Continue swirling until all these salts are dissolved.

200 ml distilled water, mix, and store at

4°c.

Add
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APPENDIX B
Pre-Reduced Chopped Meat Broth (37a)
The following are added:
Ground beef (fat free)
di sti 11 ed water
1 Normal NaOH

500g
lOOOml
25ml

Remove fat and connective tissue from lean beef before grinding.
meat, water and NaOH and bring this to a boil while stirring.

Cool

media to room temperature and then skim the fat off the surface.
the mixture retaining both meat oarticles and the filtrate.

Mix

Filter

To the

filtrate add sufficient water to restore it to the one liter original
volume.
To this filtrate add:
Trypticase

30g

Yeast Extract

5g

Potassium Phosphate

5g

resazurin solution

4ml (dissolve
25mg of resazurin powder in
lOOml distilled water).

Boil the filtrate and cool under o2-free co 2 , then add 0.5g cysteine-HCl
and 10.0ml hemin solution (dissolve 50mg of hemin in lml of lN NaOH, add
99ml of distilled water and autoclave at 121oc for 15 minutes).
PH of medium to neutrality.

Adjust

Under oxygen-free co 2 , dispense 7ml of broth
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into tubes containing meat particles (use one part meat particles to
four to five parts fluid).
121°c for 15 minutes.

Stopper tubes and autoclave in press at
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APPENDIX C
Hank's Balanced Salts Solution (HBSS) (Flow Modified)
Hank's lX Concentrated (22).
Hank's lOX concentrateda

50.0ml

Demineralized distilled water

500.0ml

lM Tris

(pH 7.3)

13. 75ml

1. lM Ca lei um Chloride (anhydrous)

0.825ml

0.4M MgS0 4
Glucose
1.4% (wt/vol) NaHC0 3
Adjusted to pH 7.2 - 7.4

1.0ml
1. lg
50.0ml

aHank's lOX Concentrated Buffer
NaCl

40.0g

KCl

2.0g

Na2HP04

0.5g

KH 2Po 4

0.5g

Demineralized distilled water

500.0ml
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